Supporting the well-being of an aging global population: associations between well-being and dementia by Britton, K, Hill, KC, Willroth, EC

Treatment of metastatic pheochromocytoma and paraganglioma with I-131-meta-iodobenzylguanidine (MIBG) by Kaltsas, G, Mukherjee, J, Foley, R, Britton, K, Grossman, AB

Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidine. by Bomanji, J, Britton, K, Ur, E, Hawkins, L, Grossman, A, Besser, G

A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octreotide) in metastatic carcinoid tumors. by Bomanji, J, Mather, S, Moyes, J, Ellison, D, Grossman, A, Britton, K, Besser, G

Localization of neuroendocrine tumours and insulinomas using radiolabelled somatostatin analogues, 123I-Tyr3-octreotide and 111In-pentatreotide. by Ur, E, Bomanji, J, Mather, S, Britton, K, Wass, J, Grossman, AB, Besser, G

99mTc-interleukin-2 scintigraphy in normal subjects and in patients with autoimmune thyroid diseases: a feasibility study. by Chianelli, M, Mather, S, Grossman, A, Sobnak, R, Fritzberg, A, Britton, K, Signore, A

The changed pattern of substrate specificity in the K89L mutant of glutamate dehydrogenase of Clostridium symbiosum. by Wang, X, Dean, J, Engel, P, Baker, P, Britton, K, Stillman, T, Rice, D

Imaging neuroendocrine tumours with radiolabelled somatostatin analogues and X-ray computed tomography: a comparative study. by King, C, Reznek, R, Bomanji, J, Ur, E, Britton, K, Grossman, AB, Besser, G

The accuracy of parathyroid gland localization in primary hyperparathyroidism using sestamibi radionuclide imaging. by Johnston, L, Carroll, M, Britton, K, Lowe, D, Shand, W, Besser, G, Grossman, A

Pituitary imaging using a labelled somatostatin analogue in acromegaly. by Ur, E, Mather, S, Bomanji, J, Ellison, D, Britton, K, Grossman, AB, Wass, J, Besser, G

A landmark-based approach for assessing the reliability of mandibular tooth crowding as a marker of dog domestication by Ameen, C, Hulme-Beaman, A, Evin, Allowen, Germonpré, M, Britton, K, Cucchi, T, Larson, GJ, Dobney, K

The role of 123I-diagnostic imaging in the follow-up of patients with differentiated thyroid carcinoma as compared to 131I-scanning: avoidance of negative therapeutic uptake due to... by Siddiqi, A, Foley, R, Britton, K, Sibtain, A, Plowman, P, Grossman, AB, Monson, J, Besser, G

Prevalence, age of onset, and natural history of thyroid disease in Pendred syndrome. by Reardon, W, Coffey, R, Chowdhury, T, Grossman, A, Jan, H, Britton, K, Kendall-Taylor, P, Trembath, R

123I-Interleukin-2: biochemical characterization and in vivo use for imaging autoimmune diseases. by Signore, A, Picarelli, A, Annovazzi, A, Britton, K, Grossman, AB, Bonanno, E, Maras, B, Barra, D, Pozzilli, P

I-123 imaging for the prediction of I-131 therapy for recurrent differentiated thyroid cancer, RDTC, when I-131 tracer is negative but raised thyroglobulin, Tg by Britton, K, Foley, R, Siddiqi, A, Jan, H, Canizales, A, Plowman, P, Grossman, AB, Monson, J, Besser, G

Carcinoid tumours presenting as breast cancer: the utility of radionuclide imaging with 123I-MIBG and 111In-DTPA pentetreotide. by Kaltsas, G, Putignano, P, Mukherjee, J, Satta, M, Lowe, D, Britton, K, Monson, J, Grossman, AB, Besser, G

Pendred syndrome--100 years of underascertainment? by Reardon, W, Coffey, R, Phelps, P, Luxon, L, Stephens, D, Kendall-Taylor, P, Britton, K, Grossman, A, Trembath, R

The catalytic role of aspartate in the active site of glutamate dehydrogenase. by Dean, J, Wang, X, Teller, J, Waugh, M, Britton, K, Baker, P, Stillman, T, Martin, SR, Rice, D, Engel, P

Metastatic parathyroid carcinoma in the MEN2A syndrome. by Jenkins, P, Satta, M, Simmgen, M, Drake, WM, Williamson, C, Lowe, D, Britton, K, Chew, S, Thakker, R, Besser, G

Radionuclide treatment of neuroendocrine tumours with the novel radiolabelled analogue Y-90-SMT 487 by Carroll, P, Maher, K, Foley, R, Stewart, P, Bevan, J, Franklyn, J, Besser, G, Monson, J, Britton, K, Grossman, AB